ANAB
Price
$48.10
Change
+$0.16 (+0.33%)
Updated
Oct 22 closing price
Capitalization
1.44B
12 days until earnings call
Intraday BUY SELL Signals
ORKA
Price
$81.14
Change
+$1.22 (+1.53%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
5.29B
20 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ANAB vs ORKA

ANAB vs ORKA Comparison Chart in %
View a ticker or compare two or three
VS
ANAB vs. ORKA commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANAB is a StrongBuy and ORKA is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ANAB with price predictions
Oct 22, 2026

ANAB's RSI Indicator ascending out of oversold territory

The RSI Indicator for ANAB moved out of oversold territory on October 14, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 21 similar instances when the indicator left oversold territory. In 18 of the 21 cases the stock moved higher. This puts the odds of a move higher at 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 48 of 60 cases where ANAB's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 80%.

The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on ANAB as a result. In 73 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 78%.

The Moving Average Convergence Divergence (MACD) for ANAB just turned positive on October 15, 2026. Looking at past instances where ANAB's MACD turned positive, the stock continued to rise in 42 of 53 cases over the following month. The odds of a continued upward trend are 79%.

Following a +5.88% 3-day Advance, the price is estimated to grow further. Considering data from situations where ANAB advanced for three days, in 223 of 283 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

ANAB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ANAB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.

The Aroon Indicator for ANAB entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 35 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 38 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating steady price growth. ANAB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 93 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ANAB's P/B Ratio (112.808) is very high in comparison to the industry average of (2.973). P/E Ratio (-47.157) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (6.614) is also within normal values, averaging (438.009).

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
a Summary for ORKA with price predictions
Oct 21, 2026

ORKA's RSI Indicator ascending out of oversold territory

The RSI Indicator for ORKA moved out of oversold territory on October 19, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 26 similar instances when the indicator left oversold territory. In 23 of the 26 cases the stock moved higher. This puts the odds of a move higher at 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 42 of 57 cases where ORKA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.

The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on ORKA as a result. In 69 of 99 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 70%.

The Moving Average Convergence Divergence (MACD) for ORKA just turned positive on October 21, 2026. Looking at past instances where ORKA's MACD turned positive, the stock continued to rise in 42 of 54 cases over the following month. The odds of a continued upward trend are 78%.

Following a +7.30% 3-day Advance, the price is estimated to grow further. Considering data from situations where ORKA advanced for three days, in 203 of 259 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.

ORKA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

ORKA moved below its 50-day moving average on September 18, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ORKA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.

The Aroon Indicator for ORKA entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.760) is normal, around the industry mean (2.988). P/E Ratio (-39.176) is within average values for comparable stocks, (-1.158). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (123.903) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).

The Tickeron PE Growth Rating for this company is 26 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. ORKA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ORKA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
ANAB vs ORKA: Fundamental Ratings
ANAB
ORKA
OUTLOOK RATING
1..100
563
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
5
Undervalued
PROFIT vs RISK RATING
1..100
38100
SMR RATING
1..100
9994
PRICE GROWTH RATING
1..100
4939
P/E GROWTH RATING
1..100
3526
SEASONALITY SCORE
1..100
6550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORKA's Valuation (5) in the null industry is significantly better than the same rating for ANAB (93) in the Biotechnology industry. This means that ORKA’s stock grew significantly faster than ANAB’s over the last 12 months.

ANAB's Profit vs Risk Rating (38) in the Biotechnology industry is somewhat better than the same rating for ORKA (100) in the null industry. This means that ANAB’s stock grew somewhat faster than ORKA’s over the last 12 months.

ORKA's SMR Rating (94) in the null industry is in the same range as ANAB (99) in the Biotechnology industry. This means that ORKA’s stock grew similarly to ANAB’s over the last 12 months.

ORKA's Price Growth Rating (39) in the null industry is in the same range as ANAB (49) in the Biotechnology industry. This means that ORKA’s stock grew similarly to ANAB’s over the last 12 months.

ORKA's P/E Growth Rating (26) in the null industry is in the same range as ANAB (35) in the Biotechnology industry. This means that ORKA’s stock grew similarly to ANAB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANABORKA
RSI
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 2 days ago
70%
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 2 days ago
71%
Advances
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 2 days ago
78%
Declines
ODDS (%)
Bearish Trend 16 days ago
81%
Bearish Trend 7 days ago
74%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 2 days ago
67%
Aroon
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 2 days ago
75%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (ANAB: $47.94 vs. ORKA: $79.92)
Brand notoriety: ANAB and ORKA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANAB: 121% vs. ORKA: 116%
Market capitalization -- ANAB: $1.44B vs. ORKA: $5.37B
ANAB [@Biotechnology] is valued at $1.44B. ORKA’s [@Biotechnology] market capitalization is $5.37B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $135.64B. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANAB’s FA Score shows that 1 FA rating(s) are green while ORKA’s FA Score has 2 green FA rating(s).

  • ANAB’s FA Score: 1 green, 4 red.
  • ORKA’s FA Score: 2 green, 3 red.
According to our system of comparison, ORKA is a better buy in the long-term than ANAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANAB’s TA Score shows that 6 TA indicator(s) are bullish while ORKA’s TA Score has 6 bullish TA indicator(s).

  • ANAB’s TA Score: 6 bullish, 2 bearish.
  • ORKA’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, ANAB is a better buy in the short-term than ORKA.

Price Growth

ANAB (@Biotechnology) experienced а +2.72% price change this week, while ORKA (@Biotechnology) price change was +4.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.10%. For the same industry, the average monthly price growth was -18.18%, and the average quarterly price growth was -15.20%.

Reported Earning Dates

ANAB is expected to report earnings on Nov 03, 2026.

ORKA is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (-1.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ANAB
Daily Signal:
Gain/Loss:
ORKA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

ANAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANAB has been loosely correlated with CLRB. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ANAB jumps, then CLRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANAB
1D Price
Change %
ANAB100%
+0.33%
CLRB - ANAB
40%
Loosely correlated
-8.59%
QTTB - ANAB
38%
Loosely correlated
+1.50%
AMRN - ANAB
38%
Loosely correlated
+0.78%
JBIO - ANAB
36%
Loosely correlated
-1.45%
ORKA - ANAB
35%
Loosely correlated
+1.54%
More

ORKA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORKA has been loosely correlated with SYRE. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ORKA jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORKA
1D Price
Change %
ORKA100%
+1.05%
SYRE - ORKA
51%
Loosely correlated
+1.70%
XNCR - ORKA
45%
Loosely correlated
+0.88%
DNTH - ORKA
43%
Loosely correlated
-0.83%
JBIO - ORKA
41%
Loosely correlated
+1.82%
TRVI - ORKA
41%
Loosely correlated
-0.47%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
AXTU25.101.90
+8.21%
T-REX 2X Long AXTI Daily Target ETF (AXTU)
PFI58.550.74
+1.28%
Invesco Dorsey Wright Financial Momentum ETF (PFI)
KGLD25.110.08
+0.32%
Kurv Gold Enhanced Income ETF
NBCM31.52-0.13
-0.41%
Neuberger Commodity Strategy ETF (NBCM)
KWEB23.74-0.61
-2.51%
KraneShares CSI China Internet ETF (KWEB)